Enter your terms above and click the 'Search' button.

Showing articles 0 to 9 of 9 Filter Applied: Parkinson disease (Click to remove) Gender Differences in Parkinsons Disease JNNP 78:819-824,787, Haaxma,C.A.,et al, 2007 The Effect of Estrogen Replacement on Early Parkinson's Disease Neurol 52:1417-1421, Sanders-Pullman,R.,et al, 1999 Postmenopausal Estrogen Use and Parkinson's Disease with and without Dementia Neurol 50:1141-1143, Marder,K.,et al, 1998 Parkinsons Disease NEJM 391:442-452, Tanner,C.M. & Ostrem,J.L., 2024 Long-Term Safety and Tolerability of ProSavin, a Lentiviral Vector-Based Gene Therapy for Parkinsons Disease: A Dose Escalation, Open-Label, Phase 1/2 Trial Lancet 383:1138-1146,1107, Palfi, S.,et al, 2014 Safety and Tolerability of Gene Therapy With an Adeno-Associated Virus (AAV) Borne GAD gene for Parkinsons Disease: An Open Label, Phase I Trial Lancet 369:2097-2105,2056, Kaplitt,M.G.,et al, 2007 Science and Ethics of Sham Surgery, A Survey of Parkinson Disease Clinical Researchers Arch Neurol 62:1357-1360,1343, Kim,S.Y.H.,et al, 2005 Distinction of Idiopathic Parkinson's Dis from Multi-Syst Atrophy by Stim of Growth-Hormone Release w Clonidine Lancet 349:1877-1881, Kimber,J.R.,et al, 1997 Gene Therapy for Neurologic Disease Arch Neurol 50:1252-1268, Suhr,S.T.&Gage,F.H., 1993 Showing articles 0 to 9 of 9